Off Label Prescriptions Removed From The Table Overly Zealous Watchdogs Interfere with Patients and their Doctors

Off Label Prescriptions Removed From The Table….

Overly Zealous Watchdogs Interfere with Patients and their Doctors

October 1, 2020 – Does a physician or the pharmacist know what is best for a patient? When the Ohio

Off Label Prescriptions Removed From The Table….  Overly Zealous Watchdogs Interfere with Patients and their Doctors   October 1, 2020 – Does a physician or the pharmacist know what is best for a patient? When the Ohio Board of Pharmacy ruled that doctors could not prescribe the off-label treatment hydroxychloroquine to treat the Coronavirus/Covid-19 pandemic it was a chilling trespass into the rights of people in Ohio and set a dangerous precedent in the other forty nine.  Medicines to treat conditions with off-label prescribing occurs when a physician stipulates a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than what a patient has. Off label prescribing is nothing new.   Unanticipated Consequences of Overly Aggressive Regulators This practice is legal and common as one in five prescriptions written today are for off-label use. The Ohio Board of Pharmacy decision was without precedent. Americans should be nervous about this instance because it puts the relationships between doctors and patients at risk and removes the judgement of physicians about how to best treat their patients, putting it into the hands of government regulators. “This overreach is a present and future danger for Americans and their doctors in the wake of the Coronavirus/Covid-19 pandemic,” Dr. Steven Goldstein told the audience on his podcast. “This puts decision making about how best to treat a patient into the hands of someone who does not know the individual, never mind has any medical experience with them.”  The Future Beyond Covid-19 The prospect that someone other than the doctor and patient are involved in this decision making is bad practice. “Doctors are trained and educated to diagnose and treat patients”, Dr. Goldstein said. “They also have experience treating their patients and know how to evaluate scientific papers about new treatments. Pharmacists and government bureaucrats do not have this training or experience.”   In the case of hydroxychloroquine there is no randomized controlled trial to prove scientifically whether or not this drug is effective for Covid-19. It is also true that there is no other treatment that has been proven with a randomized controlled trial to be effective. “Physicians should be able to use any treatment that may be beneficial to their patient,” Dr. Goldstein said. “Interference by government boards or other non-physicians will retard the development of effective treatments and lead to additional mortality and morbidity.” The next outbreak is a certainty, it’s only a matter of time. “If pharmacists and bureaucrats are getting between doctors and patients now, we should be very worried about the future,” Dr. Goldstein concluded.  About the Houston Healthcare Initiative Podcast The Houston Healthcare Initiative podcast with Dr. Steven Goldstein is an information vehicle for people who want to know all medical options for themselves and are interested in reforming the healthcare industry. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.
Overly Zealous Watchdogs Interfere with Patients and their Doctors.

Board of Pharmacy ruled that doctors could not prescribe the off-label treatment hydroxychloroquine to treat the Coronavirus/Covid-19 pandemic it was a chilling trespass into the rights of people in Ohio and set a dangerous precedent in the other forty nine.  Medicines to treat conditions with off-label prescribing occurs when a physician stipulates a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than what a patient has. Off label prescribing is nothing new

Unanticipated Consequences of Overly Aggressive Regulators

This practice is legal and common as one in five prescriptions written today are for off-label use. The Ohio Board of Pharmacy decision was without precedent. Americans should be nervous about this instance because it puts the relationships between doctors and patients at risk and removes the judgement of physicians about how to best treat their patients, putting it into the hands of government regulators. “This overreach is a present and future danger for Americans and their doctors in the wake of the Coronavirus/Covid-19 pandemic,” Dr. Steven Goldstein told the audience on his podcast. “This puts decision making about how best to treat a patient into the hands of someone who does not know the individual, never mind has any medical experience with them.”

The Future Beyond Covid-19

The prospect that someone other than the doctor and patient are involved in this decision making is bad practice. “Doctors are trained and educated to diagnose and treat patients”, Dr. Goldstein said. “They also have experience treating their patients and know how to evaluate scientific papers about new treatments. Pharmacists and government bureaucrats do not have this training or experience.

In the case of hydroxychloroquine there is no randomized controlled trial to prove scientifically whether or not this drug is effective for Covid-19. It is also true that there is no other treatment that has been proven with a randomized controlled trial to be effective. “Physicians should be able to use any treatment that may be beneficial to their patient,” Dr. Goldstein said. “Interference by government boards or other non-physicians will retard the development of effective treatments and lead to additional mortality and morbidity.” The next outbreak is a certainty, it’s only a matter of time. “If pharmacists and bureaucrats are getting between doctors and patients now, we should be very worried about the future,” Dr. Goldstein concluded.

About the Houston Healthcare Initiative Podcast

The Houston Healthcare Initiative podcast with Dr. Steven Goldstein is an information vehicle for people who want to know all medical options for themselves and are interested in reforming the healthcare industry. To hear the podcast go to: SoundCloud, iHeartRadio, Stitcher, Backtracks, LibSyn, or the website at www.houstonhealthcareinitiative.org. Dr. Goldstein insists that for the health and welfare of the American public, the congress must pass reforms that limit the influence of the pharmaceutical industry and its lobby.

 

 

How Will Healthcare Change After Coronavirus Covid-19

Rapid deployment to battle epidemics is key to winning.

How Will Healthcare Change After Coronavirus Covid-19

Doctors, hospitals, state and federal government agencies along with drug and insurance companies have all made concessions to the public during the time of the Coronavirus Covid-19 pandemic. This emergency affects every American so it stands to reason that what follows will too. But will common sense, red tape cutting, sensible changes that benefit patients remain, or be disposed of like so much medical waste? And what about preparations for future outbreaks? Houston based neurologist Dr. Steven Goldstein of the Houston Healthcare Initiative shares his views on this topic with his podcast audience. The podcast is available on iTunes, Soundcloud, Libsyn, and on www.houstonhealthcareinitiative.org.

Telemedicine

While remote access to doctors via Internet based communications is nothing new, it was never widely used until the outbreak of the Coronavirus/Covid-19 pandemic. But will patients continue to use this convenience? “It depends on what insurance companies will cover as well as what the regulations are from the state board of medical examiners,” Dr. Goldstein told his listeners. “There are plenty of good reasons to maintain this capability. Remote locations, lack of transportation resources and the reality that sick people are not keen to go to a clinic or doctor’s office whether they have the flu, a stomachache or even the Coronavirus should all help persuade the insurance industry to maintain payments for remote appointments.”

Lessons from the Pandemic – Rapid Strike Force

The speed that a viral outbreak is met with can prevent wider infection. Borrowing from an analogy coined by Bill Gates, Dr. Goldstein compared treatment to fighting a war.  “We need a standing army to spring into action when a virus is first found and ready to travel anywhere in the world to go to work,” he said.

LTC-Kryder-E-Van-Buskirk-Commander-of-the-8076th-MASH-in-Kunu-Ri-Korea-November-27
A medical rapid strike force to battle disease is one of the lessons the healthcare industry and government should apply after the Coronavirus/Covid-19 pandemic. LTC Kryder E. Van Buskirk, Commander of the 8076th MASH in Kunu- Ri, Korea, November 27, 1950. U.S. Army photograph 8A/FEC-50-22795 by CPL Fred A. Rice reprinted with permission.

Dr. Goldstein envisions teams of doctors, nurses, epidemiologists, virologists, and other medical professionals who can very quickly construct field hospitals on the site of the outbreak, isolate and treat the sick people and find treatments for them. “This would be like a ‘Mobile Army Surgical Hospital’ or MASH unit; fully equipped, staffed and right at the front line. The enemy is disease and must be fought aggressively.”

No Excuses

Goldstein thinks that the federal government must put a greater emphasis on public health and do more to keep people from getting sick. “This is not the first epidemic we’ve faced in recent years just the most recent,” Dr. Goldstein said. He described the many recent health crises the world has faced and faces including HIV/AIDS, Ebola, Zika, MERS and lately the Coronavirus/Covid-19 outbreak. “There will be no excuse for any lack of preparedness when this happens again, and we know it will happen again.”

About Dr. Steven Goldstein

The goal of Dr. Steven Goldstein and the Houston Healthcare Initiative is to be a catalyst for change in the way Americans receive and pay for medical treatment. To cause change his web site is an aggregator of information, tools, and targets for the reform of the healthcare industry with an emphasis on free market innovation and personal responsibility.